Page 3 - கேத்தரின் டெய்லர் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from கேத்தரின் டெய்லர். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In கேத்தரின் டெய்லர் Today - Breaking & Trending Today

Colum McCann's Apeirogon on Orwell Prize shortlist; TV deal for Jane Casey


 
In Saturday’s books pages, Keith Ridgway talks to John Self about A Shock, his first book in a long time; Anne MacManus talks to Una Mullally about her debut novel, Mother Mother; and David O’Doherty talks to Patrick Freyne about his new children’s book.
Reviews are Una Mullally on Rememberings by Sinéad O’Connor; Niamh Donnelly on Trouble by Philip Ó Ceallaigh; Catherine Taylor on the best new fiction in translation; Kevin Gildea on The Stranger Times by CK McDonnell; Claire Connolly on The Routledge International Handbook of Irish Studies, edited by Renée Fox, Mike Cronin and Brian Ó Conchubhair, and The New Irish Studies by Paige Reynolds; Joe Humphreys on A Hut at the Edge of the Village by John Moriarty, edited by Martin Shaw; Sarah Moss on Panenka, Rónán Hession; and Sarah Gilmartin on Malibu Rising by Taylor Reid. ....

United Kingdom , County South Dublin , City Of , William Collins , Emmet Kirwan , Paige Reynolds , Akwaeke Emezi Faber , Joe Humphreys , John Webster , Colum Mccann , Trish Lorenz , George Orwell , Jennifer Nansubuga Makumbi , Martin Shaw , Claire Connolly , Kevin Gildea , Joshua Yaffa Granta , Skellig Michael , Olivette Otele Hurst , Patrick Freyne , Keith Ridgway , Paula Cuddy , Emma Donoghue , Ingrid Lewis , Jane Casey , Taylor Reid ,

Janssen's Erleada maintains quality of life for prostate cancer patients


Janssen’s Erleada maintains quality of life for prostate cancer patients
27th May 2021
Janssen’s Erleada in addition to androgen deprivation therapy (ADT) maintained prostate cancer patients’ health-related quality of life (HRQoL), according to new patient-reported outcomes (PRO) data.
The PRO data from the prespecified final analysis of the Phase III TITAN study in patients with metastatic hormone-sensitive prostate cancer (mHSPC) also showed that the addition of Erleada (apalutamide) to ADT did not worse side effect burden.
In both treatment groups – patients who received Erleada plus ADT and patients who received placebo plus ADT – HRQoL was maintained throughout the study. ....

Janssen Erleada , Catherine Taylor , Brief Pain Inventory Short Form , Functional Assessment , Cancer Therapy Prostate , Middle East , Johnson Middle , Prostate Cancer , கேத்தரின் டெய்லர் , சுருக்கமான வலி சரக்கு குறுகிய வடிவம் , செயல்பாட்டு மதிப்பீடு , புற்றுநோய் சிகிச்சை ப்ராஸ்டேட் , நடுத்தர கிழக்கு , ஜான்சன் நடுத்தர ,